Literature DB >> 15686629

Mechanisms of cancer metastasis to the bone.

Juan Juan Yin1, Claire B Pollock, Kathleen Kelly.   

Abstract

Some of the most common human cancers, including breast cancer, prostate cancer, and lung cancer, metastasize with avidity to bone. What is the basis for their preferential growth within the bone microenvironment? Bidirectional interactions between tumor cells and cells that make up bone result in a selective advantage for tumor growth and can lead to bone destruction or new bone matrix deposition. This review discusses our current understanding of the molecular components and mechanisms that are responsible for those interactions.

Entities:  

Mesh:

Year:  2005        PMID: 15686629     DOI: 10.1038/sj.cr.7290266

Source DB:  PubMed          Journal:  Cell Res        ISSN: 1001-0602            Impact factor:   25.617


  91 in total

1.  Denosumab for the treatment of bone metastases in breast cancer: evidence and opinion.

Authors:  Guenther G Steger; Rupert Bartsch
Journal:  Ther Adv Med Oncol       Date:  2011-09       Impact factor: 8.168

Review 2.  Omentum and bone marrow: how adipocyte-rich organs create tumour microenvironments conducive for metastatic progression.

Authors:  H Chkourko Gusky; J Diedrich; O A MacDougald; I Podgorski
Journal:  Obes Rev       Date:  2016-07-19       Impact factor: 9.213

3.  Inhibition of gap junction channel attenuates the migration of breast cancer cells.

Authors:  Kai Zhao; Weili Wang; Caihong Guan; Jie Cai; Ping Wang
Journal:  Mol Biol Rep       Date:  2011-06-15       Impact factor: 2.316

Review 4.  microRNA Regulation of Skeletal Development.

Authors:  Steven R Sera; Nicole I Zur Nieden
Journal:  Curr Osteoporos Rep       Date:  2017-08       Impact factor: 5.096

5.  The chemokine CCL2 increases prostate tumor growth and bone metastasis through macrophage and osteoclast recruitment.

Authors:  Kosuke Mizutani; Sudha Sud; Natalie A McGregor; Gari Martinovski; Brandon T Rice; Matthew J Craig; Zachary S Varsos; Hernan Roca; Kenneth J Pienta
Journal:  Neoplasia       Date:  2009-11       Impact factor: 5.715

Review 6.  Chemical and biological studies of reveromycin A.

Authors:  Hiroyuki Osada
Journal:  J Antibiot (Tokyo)       Date:  2016-06-08       Impact factor: 2.649

7.  A 3D printed nano bone matrix for characterization of breast cancer cell and osteoblast interactions.

Authors:  Wei Zhu; Nathan J Castro; Haitao Cui; Xuan Zhou; Benchaa Boualam; Robert McGrane; Robert I Glazer; Lijie Grace Zhang
Journal:  Nanotechnology       Date:  2016-06-27       Impact factor: 3.874

8.  Therapeutic efficacy of soluble receptor activator of nuclear factor-kappa B-Fc delivered by nonviral gene transfer in a mouse model of osteolytic osteosarcoma.

Authors:  François Lamoureux; Gaëlle Picarda; Julie Rousseau; Clothilde Gourden; Séverine Battaglia; Céline Charrier; Bruno Pitard; Dominique Heymann; Françoise Rédini
Journal:  Mol Cancer Ther       Date:  2008-10       Impact factor: 6.261

Review 9.  Targeting selectins and selectin ligands in inflammation and cancer.

Authors:  Steven R Barthel; Jacyln D Gavino; Leyla Descheny; Charles J Dimitroff
Journal:  Expert Opin Ther Targets       Date:  2007-11       Impact factor: 6.902

10.  Diagnostic value of bone-specific alkaline phosphatase in lung carcinoma patients with bone metastases: a meta-analysis.

Authors:  Qing-Tao Zhao; Zhao-Xu Yang; Lei Yang; Dong Xing; Jing-Chao Wei; Wen-Yi Li
Journal:  Int J Clin Exp Med       Date:  2015-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.